跳至主要内容
临床试验/DRKS00006351
DRKS00006351尚未招募不适用

ongitudinal Next Generation Sequencing (NGS) in Patients with Relapsing-Remitting Multiple Sclerosis (Systematic investigation of genomic activity in patients with RR-MS)

ovartis GmbH0 个研究点目标入组 10 人开始时间: 2014年10月27日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
Female

入选标准

  • Female patients with a diagnosis of relapsing-remitting multiple sclerosis (McDonald criteria 2010)
  • - Planned conversion of MS - Therapy
  • - Patients with an age between 18 and 50
  • - No MS - relapse in the last 4 weeks
  • - Written documented consent

排除标准

  • - Signs of opportunistic infection
  • - Signs of a tumor disease
  • - (Pre-) treatment with immunsuppressive drugs (azathioprine, methotrexate, mitoxantrone, cyclophosphamide)
  • - Pregnancy
  • - Severe Depression (CES-D in Screnning> 30)
  • - Alcohol or drug abuse

研究者

发起方
ovartis GmbH

相似试验